From Wikipedia, the free encyclopedia
A-PBITMO
Identifiers
  • (Adamantan-1-yl)(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanone
Chemical and physical data
FormulaC23H30N2OS
Molar mass382.57 g·mol−1
3D model ( JSmol)
  • S=C1N(C(=O)C23CC4CC(C2)CC(C3)C4)c2ccccc2N1CCCCC

A-PBITMO is a synthetic cannabinoid receptor agonist that has been sold as a designer drug, first reported in Germany in July 2023, [1] and also subsequently identified in Russia. [2] It has an unusual 1,3-dihydrobenzimidazole-2-thione core structure which has not previously been seen in cannabinoid designer drugs.

See also

References

  1. ^ "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
  2. ^ Yurchenko RA, Yurchenko LV, Galetskaya IA, Novitsky MV, Pavlovets YS (February 2024). Psychoactive products market observation. Trend analysis (Report) (in Russian). Aipsin. doi: 10.13140/RG.2.2.10176.92163.
From Wikipedia, the free encyclopedia
A-PBITMO
Identifiers
  • (Adamantan-1-yl)(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanone
Chemical and physical data
FormulaC23H30N2OS
Molar mass382.57 g·mol−1
3D model ( JSmol)
  • S=C1N(C(=O)C23CC4CC(C2)CC(C3)C4)c2ccccc2N1CCCCC

A-PBITMO is a synthetic cannabinoid receptor agonist that has been sold as a designer drug, first reported in Germany in July 2023, [1] and also subsequently identified in Russia. [2] It has an unusual 1,3-dihydrobenzimidazole-2-thione core structure which has not previously been seen in cannabinoid designer drugs.

See also

References

  1. ^ "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
  2. ^ Yurchenko RA, Yurchenko LV, Galetskaya IA, Novitsky MV, Pavlovets YS (February 2024). Psychoactive products market observation. Trend analysis (Report) (in Russian). Aipsin. doi: 10.13140/RG.2.2.10176.92163.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook